Your browser doesn't support javascript.
loading
Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice.
Wechsler, Michael E; Peters, Stephen P; Hill, Tanisha D; Ariely, Rinat; DePietro, Michael R; Driessen, Maurice T; Terasawa, Emi L; Thomason, Darren R; Panettieri, Reynold A.
Afiliação
  • Wechsler ME; National Jewish Health, Denver, CO. Electronic address: mikewechsler@gmail.com.
  • Peters SP; Wake Forest School of Medicine, Winston-Salem, NC.
  • Hill TD; Teva Branded Pharmaceutical Products R&D Inc., West Chester, PA.
  • Ariely R; Teva Branded Pharmaceutical Products R&D Inc., West Chester, PA.
  • DePietro MR; Teva Branded Pharmaceutical Products R&D Inc., West Chester, PA.
  • Driessen MT; Teva Pharmaceutical Industries, Ltd., Amsterdam, The Netherlands.
  • Terasawa EL; Analysis Group, Inc., New York, NY.
  • Thomason DR; Analysis Group, Inc., New York, NY.
  • Panettieri RA; Rutgers University, New Brunswick, NJ.
Chest ; 159(5): 1734-1746, 2021 05.
Article em En | MEDLINE | ID: mdl-33333058

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article